EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis

Eleni Geladari, Theodoros Alexopoulos, Meropi D Kontogianni iD, Larisa Vasilieva, Iliana Mani, Roxane Tenta iD, Vasilios Sevastianos, Ioannis Vlachogiannakos, Alexandra Alexopoulou iD

Journal of Clinical Medicine · 07.05.2023 · 12 (9) · 3332

DOI: 10.3390/jcm12093332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.05.2023. Verfasst von Eleni Geladari und 8 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Internal Medicine & Liver Outpatient Clinic, Evangelismos General Hospital, 106 76 Athens, Greece. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Myosteatosis implies impaired muscle quality. The aim of the study was to investigate the association of myosteatosis with other muscle abnormalities and its role in the prognosis of liver cirrhosis (LC).

Method

Skeletal muscle index (SMI) and myosteatosis were measured by computed tomography. Myosteatosis was defined as muscle radiodensity and evaluated according to dry body mass index (BMI). Median values and interquartile range were used for continuous and count (percentage) for categorical variables.

Results

A total of 197 consecutive patients were included (age 61 (IQR 52–68); 67% male; MELD score 11 (interquartile range 7.5–16)). Myosteatosis was identified in 73.6% and sarcopenia in 44.6% of patients. Myosteatosis was positively associated with age (p = 0.024) and Child–Pugh (p = 0.017) and inversely associated with SMI (p = 0.026). Patients with myosteatosis exhibited lower 360-day survival (log-rank p = 0.001) compared to those without it. MELD (p < 0.001) and myosteatosis (p = 0.048) emerged as negative prognostic factors of survival in multivariate model. Individuals combining low muscle strength and impaired muscle quality and quantity displayed more advanced LC, impaired muscle performance, lower BMI (p < 0.001 each) and a three times higher mortality rate compared to those with low muscle quality alone.

Conclusions

The presence of myosteatosis was associated with advanced age, low skeletal mass and more severe LC. Myosteatosis was associated with poor prognosis and may represent a prodromal phase of muscle degeneration before the development of sarcopenia.

Schlagwörter

Stichwörter der Autor:innen

liver cirrhosismyosteatosissarcopeniaskeletal muscle wastingsurvival

Autor:innen und Institutionen

  • 3rd Department of Internal Medicine & Liver Outpatient Clinic, Evangelismos General Hospital, 106 76 Athens, Greece.
  • Gastroenterology Department, Medical School, National & Kapodistrian University of Athens, Laiko General Hospital, 115 27 Athens, Greece.
  • Department of Nutrition & Dietetics, School of Health Sciences and Education, Harokopio University of Athens, 176 76 Kallithea, Greece.
  • Alexandra General Hospital, Gastroenterology, 115 28 Athens, Greece.
  • 2nd Department of Internal Medicine & Research Laboratory, Medical School, National & Kapodistrian University of Athens, Hippokration General Hospital, 115 28 Athens, Greece.

ORCID-Profile: Meropi D Kontogianni, Roxane Tenta, Alexandra Alexopoulou

Zitieren

APA

Geladari, E., Alexopoulos, T., Kontogianni, M. D., Vasilieva, L., Mani, I., Tenta, R., Sevastianos, V., Vlachogiannakos, I., & Alexopoulou, A. (2023). The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis. Journal of Clinical Medicine, 12(9), 3332. https://doi.org/10.3390/jcm12093332

Vancouver

Geladari E, Alexopoulos T, Kontogianni MD, Vasilieva L, Mani I, Tenta R, et al. The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis. Journal of Clinical Medicine. 2023;12(9):3332. doi:10.3390/jcm12093332

BibTeX
@article{Geladari2023,
  author = {Geladari, Eleni and Alexopoulos, Theodoros and Kontogianni, Meropi D and Vasilieva, Larisa and Mani, Iliana and Tenta, Roxane and Sevastianos, Vasilios and Vlachogiannakos, Ioannis and Alexopoulou, Alexandra},
  title = {The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {3332},
  doi = {10.3390/jcm12093332}
}
Kostenlos starten →